BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10646846)

  • 21. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
    Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental alterations in expression and subcellular localization of antizyme and antizyme inhibitor and their functional importance in the murine mammary gland.
    Murakami Y; Suzuki J; Samejima K; Oka T
    Amino Acids; 2010 Feb; 38(2):591-601. PubMed ID: 19997757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
    Choi KS; Suh YH; Kim WH; Lee TH; Jung MH
    Biochem Biophys Res Commun; 2005 Mar; 328(1):206-12. PubMed ID: 15670771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytosolic and nuclear spermidine acetyltransferases in growing NIH 3T3 fibroblasts stimulated with serum or polyamines: relationship to polyamine-biosynthetic decarboxylases and histone acetyltransferase.
    Desiderio MA; Mattei S; Biondi G; Colombo MP
    Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):475-9. PubMed ID: 8343127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.
    Kristiansen G; Pilarsky C; Wissmann C; Kaiser S; Bruemmendorf T; Roepcke S; Dahl E; Hinzmann B; Specht T; Pervan J; Stephan C; Loening S; Dietel M; Rosenthal A
    J Pathol; 2005 Feb; 205(3):359-76. PubMed ID: 15532095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy.
    Miyake H; Muramaki M; Kurahashi T; Yamanaka K; Hara I; Gleave M; Fujisawa M
    Urology; 2006 Sep; 68(3):609-14. PubMed ID: 16979705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of polyamines, polyamine analogs, and inhibitors of protein synthesis on spermidine-spermine N1-acetyltransferase gene expression.
    Fogel-Petrovic M; Vujcic S; Brown PJ; Haddox MK; Porter CW
    Biochemistry; 1996 Nov; 35(45):14436-44. PubMed ID: 8916930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyamine analogs with xylene rings induce antizyme frameshifting, reduce ODC activity, and deplete cellular polyamines.
    Petros LM; Graminski GF; Robinson S; Burns MR; Kisiel N; Gesteland RF; Atkins JF; Kramer DL; Howard MT; Weeks RS
    J Biochem; 2006 Nov; 140(5):657-66. PubMed ID: 16998202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z; Wenlv S
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
    Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
    Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
    Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D
    Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of ornithine decarboxylase activity and histological findings in human hepatocellular carcinoma.
    Tamori A; Nishiguchi S; Kuroki T; Seki S; Kobayashi K; Kinoshita H; Otani S
    Hepatology; 1994 Nov; 20(5):1179-86. PubMed ID: 7927250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new anti-oncogene clusterin and the molecular profiling of prostate cancer progression and prognosis.
    Bettuzzi S
    Acta Biomed; 2003 Aug; 74(2):101-4. PubMed ID: 14509920
    [No Abstract]   [Full Text] [Related]  

  • 37. Polyamine metabolism in colonic mucosa from patients with ulcerative colitis.
    Obayashi M; Matsui-Yuasa I; Matsumoto T; Kitano A; Kobayashi K; Otani S
    Am J Gastroenterol; 1992 Jun; 87(6):736-40. PubMed ID: 1590311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of the androgen receptor pathway during progression of prostate cancer.
    Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
    Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy.
    Henshall SM; Horvath LG; Quinn DI; Eggleton SA; Grygiel JJ; Stricker PD; Biankin AV; Kench JG; Sutherland RL
    J Natl Cancer Inst; 2006 Oct; 98(19):1420-4. PubMed ID: 17018789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 17 is over-expressed in human prostate cancer.
    Heer R; Douglas D; Mathers ME; Robson CN; Leung HY
    J Pathol; 2004 Dec; 204(5):578-86. PubMed ID: 15538740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.